Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Eukaryotic Gene Expression
Facteur d'impact: 1.841 Facteur d'impact sur 5 ans: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimer: 1045-4403
ISSN En ligne: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v8.i2.10
pages 107-123

Interleukins in the Control of Osteoclast Differentiation

T. John Martin
St. Vincent's Institute of Medical Research and University of Melbourne Department of Medicine, Fitzroy, 3065, Victoria, Australia
E. Romas
St. Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy 3065, Victoria, Australia
M. T. Gillespie
St. Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy 3065, Victoria, Australia

RÉSUMÉ

To maintain homeostasis of bone, the production of osteoblasts and osteoclasts is tightly regulated. At the local level, hormones and cytokines control formation of osteoclasts from hemopoietic precursors by acting upon osteoblastic-stromal cells and in some cases also upon cells of the immune system. Osteoblasts regulate osteoclast formation by providing physical support and cytokines such as M-CSF and IL-11, which promote osteoclast differentiation. Osteoblasts are also a source of IL-18, which limits osteoclast formation. The requirement of contact between osteoblasts and hemopoietic cells for successful osteoclast formation led to a concept of a membrane-anchored stromal cell molecule that programs osteoclast differentiation. This mechanism has been highlighted by the discovery of osteoprotegerin (OPG), a soluble tumor necrosis factor (TNF) family member that inhibits osteoclast formation. The ligand for OPG is a novel transmembrane TNF receptor superfamily member, the osteoclast differentiating factor (ODF). The recognition of the osteoprotegerin/osteoprotegerin-ligand axis will lead to new insights into the control of osteoclast differentiation by interleukins.


Articles with similar content:

Immune Function of the Decoy Receptor Osteoprotegerin
Critical Reviews™ in Immunology, Vol.22, 2002, issue 3
Elizabeth J. Ryan, Asa K. Bengtsson
Action of RANKL and OPG for Osteoclastogenesis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.19, 2009, issue 1
Yasuhiro Kobayashi, Nobuyuki Udagawa, Naoyuki Takahashi
Perspective. Osteoclastogenesis and Growth Plate Chondrocyte Differentiation: Emergence of Convergence
Critical Reviews™ in Eukaryotic Gene Expression, Vol.13, 2003, issue 2-4
Paul R. Odgren, William M. Philbrick, Alison Gartland
Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?
Critical Reviews™ in Immunology, Vol.38, 2018, issue 4
Baohong Zhao
Control of Osteoclast Differentiation
Critical Reviews™ in Eukaryotic Gene Expression, Vol.8, 1998, issue 1
G. David Roodman, Sakamuri V. Reddy